Urol. praxi, 2015; 16(1): 29-32

Suburethral tapes for stress incontinence: ten years of experience

MUDr.Pavel Drlík1, MUDr.Jan Zmrhal, CSc.1,2, MUDr.Jiří Kočárek, Ph.D.1
1 Urologické oddělení ÚVN &ndash, VoFN, Praha
2 Gynekologicko-porodnická klinika FNKV Praha a 3. LF UK, Praha

The aim of the paper is to present our experience with implantation of suburethral TVT and TVT-O tapes. From February 2003 to May

2013, 241 women underwent placement of a suburethral tape for stress urinary incontinence at our centres. All the patients were operated

on for the first time. In 68 of them with a mean age of 62 years, retropubic tape was used. Transobturator tape was employed in

173 patients whose mean age was 57 years. Follow-up was performed at 6 and 36 months after the procedure. Subjective complaints

and the quality of life were rated using the VAS tool, and objective evaluation of the surgery effect was done by means of the Valsalva

stress test. Patients with retropubic tape were continent in 100 % and 91 % at 6 and 36 months following the procedure, respectively.

Early complications were noted in 4.4 %. With transobturator tape, full continence was maintained in 100 % and 94 % of patients at 6

and 36 months, respectively. Early complications were observed only in 1.7 % patients. The ten-year experience with the TVT and TVT-O

methods is good. According to the results, the efficacy of both surgical procedures is similar. Rates of early as well as late complications

exhibit a slight difference in favour of TVT-O. A serious haemorrhagic complication was encountered only once in the case of retropubic

tape implantation.

Keywords: stress urinary incontinence, retropubic tape, transobturator tape

Published: March 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drlík P, Zmrhal J, Kočárek J. Suburethral tapes for stress incontinence: ten years of experience. Urol. praxi. 2015;16(1):29-32.
Download citation

References

  1. Bailey KV. A Clinical Investigation into Uterine Prolapse with Stress Incontinence Treatment by modified Manchester Colporrhaphy. J. Obstet Gyneacol. Brit. Comm. 1954; 63: 663-676. Go to original source...
  2. De Lancey JOL. Structural Support of the Urethra as It Relates to Stress Urinary Incontinence: the Hammock Hypothesis. A. J. Obstet. Gynecol., 1994; 170: 1713-1723. Go to original source...
  3. Ulmsten U, Henriksson L, Johnson P. An Ambulatory Surgical Procedure under Local anesthesia for Treatment of Female Urinary Incontinence. Int. Urogynecol. J., 1996; 7: 81-86. Go to original source...
  4. Delorm E. La bandelette transobturatrice un procede mini-invasif pour traiter l'incontinence urinaire de la femme. Prog. Urol., 2001; 11: 1306-1313. Go to PubMed...
  5. Lucas MG, Bosch RJ, Burkhard FC, et al. EAU guidlines on surgical teatment of urinary incontinence. Eur. Urol. 2012; 62(6): 1118-1129. Go to original source... Go to PubMed...
  6. Cerruto MA, Artibani W. Transobturator versus retropubic synthetic slings: komparative efficancy and safety. Curr.Opin. Urol. 2011; 21(4): 275-280. Go to original source... Go to PubMed...
  7. Ogah J, Cody JD, Rogerson L. Minimally invasive suburethral sling operations for urinary incontinence in women. Cochrane Database syst. Rev., 2009; 7(4): CD006375. Go to original source... Go to PubMed...
  8. Rechberger T, Futyma K, Jankiewitz K, Adamiak A, Skorupski P. The clinical effectiveness of retropubic (IVS-02) and transobturator (IVS-04) midurethral slings: randomized trial. Eur.Urol. 2009; 56(1): 24-30. Go to original source... Go to PubMed...
  9. Barry C, Lim YN, Muller R, Hitchins S, Cortiaans A, Foote A, Greenland H, Frazer M, Rane A. A multi-centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension-free, suburethral sling treatment of urodynamic stress inkontinence: the TORP study. Int.Urogynecol. J. Pelvic Floor Dysfunct. 2007; 19(2): 171-178. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.